bioRASI Continues Explosive Growth, Purchases Ukrainian CRO
bioRASI has acquired Ukrainian CRO Sponsors Clinical Research Group (SCRG) to strengthen its position in the country's expanding research market.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs